Active tumor cell resistance to human natural killer lymphocyte attack

Area of Science:

• Immunology
• Cancer Biology
• Cellular Biology

Background:

• Natural killer (NK) cells are crucial for innate immunity against tumors.
• Tumor cells exhibit varying susceptibility to NK cell-mediated lysis.
• Mechanisms of tumor resistance to NK cell attack are not fully understood.

Purpose of the Study:

• To investigate the role of protein synthesis in tumor cell resistance to NK cell-mediated lysis.
• To determine if inhibiting protein synthesis affects NK cell activity or tumor cell susceptibility.
• To identify potential mechanisms by which tumor cells evade immune surveillance.

Main Methods:

• Human T24 bladder carcinoma (slow target) and K562 leukemia (fast target) cells were utilized.
• Protein synthesis inhibitors (cycloheximide, puromycin, emetine) were applied to tumor cells.
• NK cell-mediated cytotoxicity assays were performed.
• Tumor cells and NK effector cells were pretreated separately to discern the site of action.

Main Results:

• Inhibition of protein synthesis significantly increased NK cell-mediated lysis of slow targets (T24 cells).
• Fast targets (K562 cells) did not show increased lysis upon protein synthesis inhibition.
• The effect was localized to the tumor cells, not due to enhanced NK cell activity.
• Enhanced lysis exceeded that attributable to reduced tumor cell proliferation.

Conclusions:

• Certain human tumor cells possess active resistance mechanisms against NK cell attack.
• Protein synthesis appears to be involved in these tumor cell resistance pathways.
• This finding provides a novel model for assessing tumor cell resistance to host immune defenses.